is hers compounded semaglutide fda approved Hims Inc Hims & Hers Health stock

8 (6361 ) , 3,5 ,

For treatment periods exceeding 1.5 years, the odds ratio jumped to 2.32 (95% CI: 1.49-3.60)

The GLP-1 litigation is roughly 2.5 years in, with bellwether trials still ahead

Persons with type 2 diabetes tend to also have some degree of increased body weight or obesity and we know that achieving at least 5% body weight helps to improve glucose and cardiometabolic risk factors. MNT spoke with Jennifer Cheng, DO, chief of endocrinology at Hackensack Meridian Jersey Shore University Medical Center in New Jersey who was not involved in this study who commented it is important to find new options for the treatment of type 2 diabetes and give patients the choice of administering either via subcutaneous injections or just a daily pill